These results support our experimental in vitro findings that ELF3 activity contributes to malignant cell proliferation, that high ELF3 expression is associated with cell cycle progression in human breast tumors, and finally that ELF3 may serve as a biomarker of progression free survival. The gene discussed is ELF3; the disease is breast neoplasm.